Literature DB >> 29751942

A meta-analytic review of self-reported, clinician-rated, and performance-based motivation measures in schizophrenia: Are we measuring the same "stuff"?

Lauren Luther1, Ruth L Firmin2, Paul H Lysaker3, Kyle S Minor2, Michelle P Salyers2.   

Abstract

An array of self-reported, clinician-rated, and performance-based measures has been used to assess motivation in schizophrenia; however, the convergent validity evidence for these motivation assessment methods is mixed. The current study is a series of meta-analyses that summarize the relationships between methods of motivation measurement in 45 studies of people with schizophrenia. The overall mean effect size between self-reported and clinician-rated motivation measures (r = 0.27, k = 33) was significant, positive, and approaching medium in magnitude, and the overall effect size between performance-based and clinician-rated motivation measures (r = 0.21, k = 11) was positive, significant, and small in magnitude. The overall mean effect size between self-reported and performance-based motivation measures was negligible and non-significant (r = -0.001, k = 2), but this meta-analysis was underpowered. Findings suggest modest convergent validity between clinician-rated and both self-reported and performance-based motivation measures, but additional work is needed to clarify the convergent validity between self-reported and performance-based measures. Further, there is likely more variability than similarity in the underlying construct that is being assessed across the three methods, particularly between the performance-based and other motivation measurement types. These motivation assessment methods should not be used interchangeably, and measures should be more precisely described as the specific motivational construct or domain they are capturing.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apathy; Avolition; Measurement; Meta-analysis; Psychosis

Mesh:

Year:  2018        PMID: 29751942      PMCID: PMC6083441          DOI: 10.1016/j.cpr.2018.04.001

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  82 in total

1.  Intrinsic and Extrinsic Motivations: Classic Definitions and New Directions.

Authors: 
Journal:  Contemp Educ Psychol       Date:  2000-01

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 3.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

4.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

5.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

6.  Measuring motivation in people with schizophrenia.

Authors:  Gagan Fervaha; George Foussias; Hiroyoshi Takeuchi; Ofer Agid; Gary Remington
Journal:  Schizophr Res       Date:  2015-09-29       Impact factor: 4.939

7.  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Authors:  Michael F Green; Gerhard Hellemann; William P Horan; Junghee Lee; Jonathan K Wynn
Journal:  Arch Gen Psychiatry       Date:  2012-12

8.  Negative symptoms of schizophrenia are associated with abnormal effort-cost computations.

Authors:  James M Gold; Gregory P Strauss; James A Waltz; Benjamin M Robinson; Jamie K Brown; Michael J Frank
Journal:  Biol Psychiatry       Date:  2013-02-07       Impact factor: 13.382

9.  Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: testing mediator and moderator effects.

Authors:  Eri Nakagami; Bin Xie; Maanse Hoe; John S Brekke
Journal:  Schizophr Res       Date:  2008-08-19       Impact factor: 4.939

Review 10.  Negative symptoms in schizophrenia: avolition and Occam's razor.

Authors:  George Foussias; Gary Remington
Journal:  Schizophr Bull       Date:  2008-07-21       Impact factor: 9.306

View more
  10 in total

1.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

2.  Digital phenotyping of negative symptoms: the relationship to clinician ratings.

Authors:  Alex S Cohen; Elana Schwartz; Thanh P Le; Tovah Cowan; Brian Kirkpatrick; Ian M Raugh; Gregory P Strauss
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

3.  Bridge centrality network structure of negative symptoms in people with schizophrenia.

Authors:  Ling-Ling Wang; Michelle H W Tam; Karen K Y Ho; Karen S Y Hung; Jessica O Y Wong; Simon S Y Lui; Raymond C K Chan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-08-16       Impact factor: 5.760

4.  Self-Report Measures of Anhedonia and Approach Motivation Weakly Correspond to Anhedonia and Depression Assessed via Clinical Interviews.

Authors:  Paul J Silvia; Kari M Eddington; Kathleen H Maloney; Jaimie M Lunsford; Kelly L Harper; Thomas R Kwapil
Journal:  Pers Individ Dif       Date:  2021-04-30

Review 5.  Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development.

Authors:  Gregory P Strauss; Lisa A Bartolomeo; Philip D Harvey
Journal:  NPJ Schizophr       Date:  2021-02-26

6.  Impaired Effort Allocation in Patients with Recent-Onset Schizophrenia and Its Relevance to Negative Symptoms Assessments and Persistent Negative Symptoms.

Authors:  Ezgi Ince Guliyev; Sinan Guloksuz; Alp Ucok
Journal:  J Clin Med       Date:  2022-08-28       Impact factor: 4.964

7.  The effect of salience of rewards on effort-based decision making in psychotic disorders.

Authors:  Katharina E Renz; Tania M Lincoln
Journal:  BMC Psychiatry       Date:  2022-10-13       Impact factor: 4.144

8.  Metacognition moderates the relationship between self-reported and clinician-rated motivation in schizophrenia.

Authors:  Lauren Luther; Kelsey A Bonfils; Melanie W Fischer; Annalee V Johnson-Kwochka; Michelle P Salyers
Journal:  Schizophr Res Cogn       Date:  2019-04-17

9.  Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis.

Authors:  Skylar Luu; Haley Province; Elizabeth Berry-Kravis; Randi Hagerman; David Hessl; Dhananjay Vaidya; Reymundo Lozano; Hilary Rosselot; Craig Erickson; Walter E Kaufmann; Dejan B Budimirovic
Journal:  Brain Sci       Date:  2020-09-11

10.  Uncontrolled trial of specialized, multi-component care for individuals with first-episode psychosis: Effects on motivation orientations.

Authors:  Nicholas J K Breitborde; Jacob G Pine; Aubrey M Moe
Journal:  Early Interv Psychiatry       Date:  2019-12-30       Impact factor: 2.721

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.